PREMMi, a new approach in mitochondrial medicine
New algorithmic analysis tools will also be developed for use in mitochondrial medicine as part of the PREMMi project (Pôle de REcherche en Médecine Mitochondriale). This research project is based on the fact that in addition to rare, hereditary mitochondrial illnesses, mitochondria, which produce approximately 90% of cellular energy, are implicated in a high number of common neurodegenerative and metabolic diseases and cancers. These include a range of pathologies, including Alzheimer’s disease, Parkinson’s disease, diabetes, obesity, cancer, and diseases associated with old age. However, until now, therapeutic pathways that directly target the mitochondrion have only been used very rarely for these diseases. This project on personalised and precision mitochondrial medicine uses large volumes of data in different “omic” fields, justifying its inclusion in a programme focusing on the issues surrounding big data.